Clinical Trial: A Study to Compare Different Doses of RO7795081 With a Placebo or Semaglutide in People With Type 2 Diabetes

U.S., Aug. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07112872) titled 'A Study to Compare Different Doses of RO7795081 With a Placebo or Semaglutide in People With Type 2 Diabetes' on Aug. 01.

Brief Summary: This multicenter, randomized, double-blind, placebo- and open-label active comparator-controlled, parallel-group, dose-range-finding, Phase II study aims to evaluate the efficacy, tolerability, and safety of RO7795081 for glycemic control in adult participants with Type 2 diabetes mellitus (T2D).

Study Start Date: Aug. 31

Study Type: INTERVENTIONAL

Condition: Type 2 Diabetes Mellitus

Intervention: DRUG: RO7795081

RO7795081 will be taken orally once daily (QD), according to the randomized dosi...